Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001420437) titled 'Efficacy of Tight Versus Moderate Glycemic Control on the Rate of Surgical Site Infection in Patients with Diabetes Mellitus Undergoing Coronary Artery Bypass Graft (CABG) -A Single Centre Prospective Randomized Control Trial' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Sarawak Consolidated Industries
Condition:
Heart Surgery
Surgical Site Infection
Diabetes Mellitus Type 2
Heart Surgery
Surgical Site Infection
Diabetes Mellitus Type 2...